The Appbakery team has been working hard through the pandemic to release its new version with improved capabilities and smoother user experience. The one thing the pandemic taught us is to remain connected always. So as we take on the challenge of tackling covid together,...
TrialX Appbakery has released the Zing PainApp developed for the research team at Northwestern University working on neurogenic pain. Postoperative pain management is challenging and the Zing PainApp developed for the plastic surgery research team led by Dr. Gregory Dumanian, allows patients undergoing plastic surgery...
In the latest release of V3.11, CenterWatch iConnect has been successfully integrated with Exostar - a key identity and SSO provider for large pharma companies and we are live with this feature on Pfizer. Integration with Exostar, involves subscribing a Site user (Investigators / Other site...
During this global pandemic thousands of people in the United States are helping scientists better understand the novel coronavirus. Those infected with the virus as well as healthy volunteers are participating in research that is powering the science that will lead to new treatments and...
TrialX assists academic medical centers in recruitment for clinical research by offering iConnect, a patient friendly, centralized trial listing and recruitment platform. We proudly support research recruitment at Penn Medicine, Indiana CTSI, NYU and BIDMC. Below is a list of COVID-19 trials currently being conducted. This...
Matching the right patient to the right trial remains the most challenging task in the success of any clinical trial. This Clinical Trials day, our partners WCG (WIRB-Copernicus Group) organized the first invite only roundtable to share how iConnect - our patient recruitment platform is...
We were invited to the White House on 28th of February, 2019 to present Lyme Tracker - a digital tool we built for The Opportunity Project (TOP) Health sprint - to aid Lyme disease research and management by providing people an app to track their...